# Lattice Semiconductor Corp: financial statements, quarterly

LSCC · Nasdaq · CIK 855658 · [Technology](/sectors/technology.md) · fiscal year ends Jan 2

Pages: [Overview](/companies/lscc.md) · [Financials](/companies/lscc/financials.md) · [Filings](/companies/lscc/filings.md) · [Insiders](/companies/lscc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/lscc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | Q4 FY2024 (2024-12-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q4 FY2025 (2026-01-03) | Q1 FY2026 (2026-04-04) | Q2 FY2026 (2026-07-04) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [192](/filings/0001437749-24-033136.md) | [171 d](/filings/0001437749-26-004100.md) | [141](/filings/0001437749-25-014540.md) | [124](/filings/0001437749-25-024620.md) | [127](/filings/0001437749-25-032777.md) | [117 d](/filings/0001437749-26-004100.md) | [120](/filings/0001437749-26-014686.md) | [124](/filings/0001437749-26-025657.md) | [133](/filings/0001437749-25-032777.md) | [146 d](/filings/0001437749-26-004100.md) | [171](/filings/0001437749-26-014686.md) | [201](/filings/0001437749-26-025657.md) |
| Cost of revenue | $m | [57.6](/filings/0001437749-24-033136.md) | [51.6 d](/filings/0001437749-26-004100.md) | [44.6](/filings/0001437749-25-014540.md) | [39.3](/filings/0001437749-25-024620.md) | [39.4](/filings/0001437749-25-032777.md) | [45.7 d](/filings/0001437749-26-004100.md) | [38.4](/filings/0001437749-26-014686.md) | [39.2](/filings/0001437749-26-025657.md) | [42.8](/filings/0001437749-25-032777.md) | [45.9 d](/filings/0001437749-26-004100.md) | [53.3](/filings/0001437749-26-014686.md) | [59.7](/filings/0001437749-26-025657.md) |
| Gross profit | $m | [135](/filings/0001437749-24-033136.md) | [119 d](/filings/0001437749-26-004100.md) | [96.2](/filings/0001437749-25-014540.md) | [84.8](/filings/0001437749-25-024620.md) | [87.7](/filings/0001437749-25-032777.md) | [71.8 d](/filings/0001437749-26-004100.md) | [81.7](/filings/0001437749-26-014686.md) | [84.8](/filings/0001437749-26-025657.md) | [90.5](/filings/0001437749-25-032777.md) | [99.9 d](/filings/0001437749-26-004100.md) | [118](/filings/0001437749-26-014686.md) | [141](/filings/0001437749-26-025657.md) |
| Research and development | $m | [42.0](/filings/0001437749-24-033136.md) | [39.8 d](/filings/0001437749-26-004100.md) | [40.6](/filings/0001437749-25-014540.md) | [38.7](/filings/0001437749-25-024620.md) | [41.4](/filings/0001437749-25-032777.md) | [38.6 d](/filings/0001437749-26-004100.md) | [41.4](/filings/0001437749-26-014686.md) | [43.5](/filings/0001437749-26-025657.md) | [49.6](/filings/0001437749-25-032777.md) | [53.4 d](/filings/0001437749-26-004100.md) | [50.8](/filings/0001437749-26-014686.md) | [64.2](/filings/0001437749-26-025657.md) |
| Selling, general and administrative | $m | [33.2](/filings/0001437749-24-033136.md) | [34.7 d](/filings/0001437749-26-004100.md) | [36.5](/filings/0001437749-25-014540.md) | [20.0](/filings/0001437749-25-024620.md) | [31.0](/filings/0001437749-25-032777.md) | [29.5 d](/filings/0001437749-26-004100.md) | [33.1](/filings/0001437749-26-014686.md) | [34.8](/filings/0001437749-26-025657.md) | [41.4](/filings/0001437749-25-032777.md) | [44.3 d](/filings/0001437749-26-004100.md) | [40.1](/filings/0001437749-26-014686.md) | [50.3](/filings/0001437749-26-025657.md) |
| Operating income | $m | [56.9](/filings/0001437749-24-033136.md) | [43.1 d](/filings/0001437749-26-004100.md) | [16.6](/filings/0001437749-25-014540.md) | [22.6](/filings/0001437749-25-024620.md) | [7.5](/filings/0001437749-25-032777.md) | [(12.2) d](/filings/0001437749-26-004100.md) | [7.0](/filings/0001437749-26-014686.md) | [4.7](/filings/0001437749-26-025657.md) | [(1.5)](/filings/0001437749-25-032777.md) | [1.1 d](/filings/0001437749-26-004100.md) | [26.1](/filings/0001437749-26-014686.md) | [22.4](/filings/0001437749-26-025657.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [4.1](/filings/0001437749-24-033136.md) | [(53.3) d](/filings/0001437749-26-004100.md) | [3.0](/filings/0001437749-25-014540.md) | [1.1](/filings/0001437749-25-024620.md) | [1.0](/filings/0001437749-25-032777.md) | [(30.1) d](/filings/0001437749-26-004100.md) | [3.0](/filings/0001437749-26-014686.md) | [2.2](/filings/0001437749-26-025657.md) | [(3.7)](/filings/0001437749-25-032777.md) | [8.9 d](/filings/0001437749-26-004100.md) | [5.4](/filings/0001437749-26-014686.md) | [(2.1)](/filings/0001437749-26-025657.md) |
| Net income | $m | [53.8](/filings/0001437749-24-033136.md) | [98.7 d](/filings/0001437749-26-004100.md) | [14.8](/filings/0001437749-25-014540.md) | [22.6](/filings/0001437749-25-024620.md) | [7.2](/filings/0001437749-25-032777.md) | [16.5 d](/filings/0001437749-26-004100.md) | [5.0](/filings/0001437749-26-014686.md) | [2.9](/filings/0001437749-26-025657.md) | [2.8](/filings/0001437749-25-032777.md) | [(7.6) d](/filings/0001437749-26-004100.md) | [21.8](/filings/0001437749-26-014686.md) | [19.4](/filings/0001437749-26-025657.md) |
| Diluted EPS | $ per share | [0.38](/filings/0001437749-24-033136.md) | not reported | [0.11](/filings/0001437749-25-014540.md) | [0.16](/filings/0001437749-25-024620.md) | [0.05](/filings/0001437749-25-032777.md) | not reported | [0.04](/filings/0001437749-26-014686.md) | [0.02](/filings/0001437749-26-025657.md) | [0.02](/filings/0001437749-25-032777.md) | not reported | [0.16](/filings/0001437749-26-014686.md) | [0.14](/filings/0001437749-26-025657.md) |
| Basic EPS | $ per share | [0.39](/filings/0001437749-24-033136.md) | not reported | [0.11](/filings/0001437749-25-014540.md) | [0.16](/filings/0001437749-25-024620.md) | [0.05](/filings/0001437749-25-032777.md) | not reported | [0.04](/filings/0001437749-26-014686.md) | [0.02](/filings/0001437749-26-025657.md) | [0.02](/filings/0001437749-25-032777.md) | not reported | [0.16](/filings/0001437749-26-014686.md) | [0.14](/filings/0001437749-26-025657.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | FY2024 (2024-12-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | FY2025 (2026-01-03) | Q1 FY2026 (2026-04-04) | Q2 FY2026 (2026-07-04) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [114](/filings/0001437749-23-029543.md) | [128](/filings/0001437749-25-003987.md) | [107](/filings/0001437749-24-013962.md) | [109](/filings/0001437749-24-023930.md) | [124](/filings/0001437749-24-033136.md) | [136](/filings/0001437749-26-004100.md) | [128](/filings/0001437749-25-014540.md) | [107](/filings/0001437749-25-024620.md) | [118](/filings/0001437749-25-032777.md) | [134](/filings/0001437749-26-025657.md) | [140](/filings/0001437749-26-014686.md) | [173](/filings/0001437749-26-025657.md) |
| Current assets | $m | [361](/filings/0001437749-23-029543.md) | [368](/filings/0001437749-25-003987.md) | [341](/filings/0001437749-24-013962.md) | [353](/filings/0001437749-24-023930.md) | [366](/filings/0001437749-24-033136.md) | [365](/filings/0001437749-26-004100.md) | [338](/filings/0001437749-25-014540.md) | [322](/filings/0001437749-25-024620.md) | [342](/filings/0001437749-25-032777.md) | [364](/filings/0001437749-26-025657.md) | [386](/filings/0001437749-26-014686.md) | [438](/filings/0001437749-26-025657.md) |
| Total assets | $m | [780](/filings/0001437749-23-029543.md) | [841](/filings/0001437749-25-003987.md) | [816](/filings/0001437749-24-013962.md) | [828](/filings/0001437749-24-023930.md) | [854](/filings/0001437749-24-033136.md) | [844](/filings/0001437749-26-004100.md) | [824](/filings/0001437749-25-014540.md) | [809](/filings/0001437749-25-024620.md) | [844](/filings/0001437749-25-032777.md) | [883](/filings/0001437749-26-025657.md) | [899](/filings/0001437749-26-014686.md) | [976](/filings/0001437749-26-025657.md) |
| Current liabilities | $m | [101](/filings/0001437749-23-029543.md) | [97.4](/filings/0001437749-25-003987.md) | [81.6](/filings/0001437749-24-013962.md) | [80.3](/filings/0001437749-24-023930.md) | [92.0](/filings/0001437749-24-033136.md) | [99.6](/filings/0001437749-26-004100.md) | [78.5](/filings/0001437749-25-014540.md) | [86.9](/filings/0001437749-25-024620.md) | [106](/filings/0001437749-25-032777.md) | [118](/filings/0001437749-26-025657.md) | [111](/filings/0001437749-26-014686.md) | [145](/filings/0001437749-26-025657.md) |
| Total liabilities | $m | [153](/filings/0001437749-23-029543.md) | [149](/filings/0001437749-25-003987.md) | [133](/filings/0001437749-24-013962.md) | [129](/filings/0001437749-24-023930.md) | [150](/filings/0001437749-24-033136.md) | [133](/filings/0001437749-26-004100.md) | [116](/filings/0001437749-25-014540.md) | [122](/filings/0001437749-25-024620.md) | [138](/filings/0001437749-25-032777.md) | [169](/filings/0001437749-26-025657.md) | [159](/filings/0001437749-26-014686.md) | [189](/filings/0001437749-26-025657.md) |
| Long-term debt | $m | [0.0](/filings/0001437749-23-029543.md) | [0.0](/filings/0001437749-24-004522.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [626](/filings/0001437749-24-033136.md) | [692](/filings/0001437749-26-004100.md) | [683](/filings/0001437749-25-024620.md) | [699](/filings/0001437749-25-032777.md) | [704](/filings/0001437749-25-032777.md) | [711](/filings/0001437749-26-025657.md) | [708](/filings/0001437749-26-025657.md) | [687](/filings/0001437749-26-025657.md) | [706](/filings/0001437749-25-032777.md) | [714](/filings/0001437749-26-025657.md) | [740](/filings/0001437749-26-025657.md) | [788](/filings/0001437749-26-025657.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | Q4 FY2024 (2024-12-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q4 FY2025 (2026-01-03) | Q1 FY2026 (2026-04-04) | Q2 FY2026 (2026-07-04) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [82.2 d](/filings/0001437749-24-033136.md) | [72.0 d](/filings/0001437749-26-004100.md) | [29.5](/filings/0001437749-25-014540.md) | [21.9 d](/filings/0001437749-25-024620.md) | [44.0 d](/filings/0001437749-25-032777.md) | [45.4 d](/filings/0001437749-26-004100.md) | [31.9](/filings/0001437749-26-014686.md) | [38.5 d](/filings/0001437749-26-025657.md) | [47.1 d](/filings/0001437749-25-032777.md) | [57.6 d](/filings/0001437749-26-004100.md) | [50.3](/filings/0001437749-26-014686.md) | [88.3 d](/filings/0001437749-26-025657.md) |
| Capital expenditure | $m | [4.4 d](/filings/0001437749-24-033136.md) | [3.7 d](/filings/0001437749-26-004100.md) | [3.4](/filings/0001437749-25-014540.md) | [7.2 d](/filings/0001437749-25-024620.md) | [4.7 d](/filings/0001437749-25-032777.md) | [5.8 d](/filings/0001437749-26-004100.md) | [8.6](/filings/0001437749-26-014686.md) | [7.2 d](/filings/0001437749-26-025657.md) | [13.1 d](/filings/0001437749-25-032777.md) | [13.6 d](/filings/0001437749-26-004100.md) | [10.5](/filings/0001437749-26-014686.md) | [7.0 d](/filings/0001437749-26-025657.md) |
| Share repurchases | $m | [10.0 d](/filings/0001437749-24-033136.md) | [50.0 d](/filings/0001437749-26-004100.md) | [20.0](/filings/0001437749-25-014540.md) | [10.0 d](/filings/0001437749-25-024620.md) | [17.0 d](/filings/0001437749-25-032777.md) | [20.0 d](/filings/0001437749-26-004100.md) | [25.0](/filings/0001437749-26-014686.md) | [45.9 d](/filings/0001437749-26-025657.md) | [15.0 d](/filings/0001437749-25-032777.md) | [14.1 d](/filings/0001437749-26-004100.md) | [15.0](/filings/0001437749-26-014686.md) | [0.0 d](/filings/0001437749-26-025657.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-10-01) | Q1 FY2023 (2023-04-01) | Q2 FY2023 (2023-07-01) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q1 FY2026 (2026-04-04) | Q2 FY2026 (2026-07-04) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [140](/filings/0001437749-23-029543.md) | [140](/filings/0001437749-24-013962.md) | [140](/filings/0001437749-24-023930.md) | [140](/filings/0001437749-24-033136.md) | [139](/filings/0001437749-25-014540.md) | [138](/filings/0001437749-25-024620.md) | [138](/filings/0001437749-25-032777.md) | [138](/filings/0001437749-26-014686.md) | [138](/filings/0001437749-26-025657.md) | [138](/filings/0001437749-25-032777.md) | [139](/filings/0001437749-26-014686.md) | [140](/filings/0001437749-26-025657.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 142,030,272 at 2026-07-30, from the cover of the [10-Q filed 2026-08-04](/filings/0001437749-26-025657.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:26 ET. No prices; not investment advice.